LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |